Patent directory · USPTO A61K / A61P
Patents matching “Regenacy Pharmaceuticals, Inc.”
13 pharma patents match "Regenacy Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 13 pharmaceutical patents matching "Regenacy Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11702389
Piperidine derivatives as HDAC1/2 inhibitors
granted -
US 11542242
Substituted piperazines as selective HDAC1,2 inhibitors
granted -
US 10968180
Piperidine derivatives as HDAC1/2 inhibitors
granted -
US 10858323
HDAC inhibitors for the treatment of diabetic peripheral neuropathy
granted -
US 10774056
Substituted piperazines as selective HDAC1,2 inhibitors
granted -
US 10385031
Substituted piperazines as selective HDAC1,2 inhibitors
granted -
US 10358421
Piperidine derivatives as HDAC1/2 inhibitors
granted -
US 10239837
Piperidine derivatives as HDAC1/2 inhibitors
granted -
US 10125131
Selective HDAC3 inhibitors
granted -
US 10040769
HDAC inhibitors for the treatment of diabetic peripheral neuropathy
granted -
US 9957259
Selective HDAC1 and HDAC2 inhibitors
granted -
US 9790180
Piperidine derivatives as HDAC1/2 inhibitors
granted -
US 9765066
Selective HDAC1 and HDAC2 inhibitors
granted